Use of ketamine to facilitate opioid withdrawal in a child [16]

Anesthesiology

Volumn 104, Issue 5, 2006, Pages 1113-

  Ito, Hiroaki ^a   Sobue, Kazuya ^b   Hirate, Hiroyuki ^b   Sugiura, Takeshi ^b   So, MinHye ^b   Azami, Takafumi ^b   Sasano, Hiroshi ^b   Katsuya, Hirotada ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; FLUMAZENIL; KETAMINE; MIDAZOLAM; NALOXONE; OPIATE; SEVOFLURANE;

ARTIFICIAL VENTILATION; CASE REPORT; CHILD; CRITICALLY ILL PATIENT; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG USE; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; LETTER; OPIATE ADDICTION; PRIORITY JOURNAL; SEDATION; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANESTHETICS, DISSOCIATIVE; CHILD, PRESCHOOL; FEMALE; FENTANYL; HUMANS; KETAMINE; PAIN, POSTOPERATIVE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33646815628     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200605000-00043     Document Type: Letter

References (7)

1. Mark CM, Rosenberg DI, Ambuel B, Hamlett KW, Blumer JL: Pediatric intensive care sedation: Survey of fellowship training programs. Pediatrics 1993;91:369-78
2. Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW: The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology 2001; 157:1-10
3. Trujillo KA, Akil H: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251:85-7
4. Freye E, Partecke LB, Levy JV: Increase in delta- and beta-wave activity of the EEG during rapid opiate detoxification (ROD)-reversal by administration of the non-specific NMDA-antagonist S+ ketamine. Neurophysiol Clin 2005; 35:25-32
5. Sircar R: Developmental maturation of N-methyl-D-aspartic acid receptor complex in postnatal rat brain. Int J Dev Neurosci 2000; 130:121-31
6. Zhu H, Barr GA: Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat. Pain 2003; 104:437-47
7. Herlenius E, Lagercrantz H: Development of neurotransmitter systems during critical periods. Exp Neurol 2004; 190:S8-21